002004SZSE

2025 Board of Directors Work Report

✨ AI Summary

The Board of Directors reports on its 2025 work, adhering to laws and regulations. Key financial figures show a slight revenue decrease but significant profit increases. The report details board and shareholder meeting activities, director elections, independent director duties, committee performance, information disclosure, and investor relations, outlining plans for 2026.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_documentSign In to Upgrade

2025 Board of Directors Work Report

In 2025, the Board of Directors, with a sense of responsibility to the company and all shareholders, strictly abided by the "Company Law of the People's Republic of China" (hereinafter referred to as the "Company Law"), the "Securities Law of the People's Republic of China" (hereinafter referred to as the "Securities Law"), and other relevant laws and regulations, as well as the "Articles of Association of Huabang Life Health Co., Ltd." (hereinafter referred to as the "Articles of Association") and the "Rules of Procedure for Board Meetings" and other relevant regulations. The Board fully leveraged its decision-making and strategic management functions. It strictly implemented the decisions of the Shareholders' Meeting, actively promoted the implementation of Board resolutions, fully utilized the performance of each special committee and independent directors in the company's development, ensured the standardized and efficient operation of the Board, prudent and scientific decision-making, and effectively protected the legitimate rights and interests of all shareholders. The company's 2025 work situation and 2026 work plan are hereby reported as follows:

I. 2025 Company Operating Situation

In 2025, the company achieved a total operating revenue of 1,151,234.72 million yuan, a decrease of 15,232.26 million yuan compared to the same period last year, a year-on-year decrease of 1.31%; operating profit was 104,658.58 million yuan, an increase of 117,402.08 million yuan compared to the same period last year, a year-on-year increase of 921.27%; net profit attributable to shareholders of the listed company was 71,318.83 million yuan, an increase of 101,217.83 million yuan compared to the same period last year, a year-on-year increase of 338.53%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 64,310.90 million yuan, an increase of 98,096.13 million yuan compared to the same period last year, a year-on-year increase of 290.35%.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.